Literature DB >> 21229066

Prophylactic ASA against Myocardial Infarction: Physician Attitudes and Practices.

P McNamara, G Hardacre, D Macdiarmid, S Unger, D Kerbel.   

Abstract

Of 172 physicians surveyed to determine their attitudes and practices of using acetylsalicylic acid (ASA) as primary prophylaxis against myocardial infarction in asymptomatic male patients older than 40 years, 71.4% were aware of recent, highly publicized studies on this issue. Only 8.1% regularly recommend the use of ASA to this group of patients; 54.6% seldom or never recommend it.

Entities:  

Year:  1991        PMID: 21229066      PMCID: PMC2145641     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  3 in total

1.  Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors:  H J Weiss; L M Aledort
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

2.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

Authors:  J A Cairns; M Gent; J Singer; K J Finnie; G M Froggatt; D A Holder; G Jablonsky; W J Kostuk; L J Melendez; M G Myers
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

3.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.

Authors:  H D Lewis; J W Davis; D G Archibald; W E Steinke; T C Smitherman; J E Doherty; H W Schnaper; M M LeWinter; E Linares; J M Pouget; S C Sabharwal; E Chesler; H DeMots
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

  3 in total
  2 in total

1.  Are you a maximalist, a minimalist, or a ritualist?

Authors:  M Jeyapragasan; B Morris
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

2.  Psychosocial risk factors during pregnancy. What do family physicians ask about?

Authors:  J C Carroll; A J Reid; A Biringer; L M Wilson; D K Midmer
Journal:  Can Fam Physician       Date:  1994-07       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.